Minerva S.A. MRVSY
Set alert
1.88 USD -0.17 -8.29%
As of Nov 3, 10:27 AM ET
1.87 Day range 1.96
1.87 52-week range 5.39
- YTD
- -53.69%
- 1 year
- -62.10%
- Open
- 1.96
- Prev close
- 2.05
- Mkt cap
- 466.11M
- Vol
- 6.87K
- Avg vol
- 7.27K
- EPS
- 0.29
- P/E
- 6.48
More statistics
- Low
- 1.87
- High
- 1.96
2Y chart
Events in this range
- May 27, 2025Dividend: 0.12981
- Dec 26, 2025Dividend: 0.11634
- May 14, 2026Dividend: 0.025135
Signals (117)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Nov 3, 2026 | 2 hours ago |
| RSI: Oversold | Oct 30, 2026 | 4 days ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 20, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
Newest 20 of 117.
News
- Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London
- Minerva Neurosciences to Host In-Person KOL Event to Discuss Roluperidone for Negative Symptoms of Schizophrenia
- Minerva (OTCMKTS:MRVSY) Stock Price Breaks Below Two Hundred Day Moving Average – Should You Sell?
- Minerva S.A. (OTCMKTS:MRVSY) Short Interest Update
- Minerva Neurosciences to Participate in Two Upcoming Investor Conferences
- MINERVA FOODS REPORTS RECORD NET REVENUE OF R$ 57,2 BILLION FOR THE PAST 12 MONTHS
- Minerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates
- Minerva Launches AI Platform for Consumer Marketing with $20M from The General Partnership, 8VC, Lingotto Innovation, Topology Ventures and NBA Investments, Alongside OpenAI Collaboration
- Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs
- Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference
Your note
Sign in to keep a note on MRVSY — it syncs with the Stock Master app.